Acesso livre
Acesso livre

Infectologia

Revisão | Síndrome da COVID-19 pós-aguda.

14 Mar, 2022 | 14:01h

Post-acute COVID-19 syndrome – European Respiratory Journal

Conteúdos relacionados:

ESCMID rapid guidelines for assessment and management of long COVID.

ERS statement on Long COVID-19 follow-up.

Proposed subtypes of long-Covid and their respective potential therapies.

EuGMS Guidance: Management of post-acute COVID-19 patients in geriatric rehabilitation.

Addressing Post-COVID Symptoms: A Guide for Primary Care Physicians.

Global surveillance, research, and collaboration needed to improve understanding and management of long COVID.

Provocative study suggests that persistent physical symptoms after COVID-19 infection may be associated more with the belief in having been infected with SARS-CoV-2 than with having laboratory-confirmed COVID-19 infection.

Update to post-acute sequelae of SARS-CoV-2 infection: Caring for the ‘long-haulers’.

Systematic Review: Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection.

WHO Consensus: A clinical case definition of post COVID-19 condition (Long Covid).

Characterizing long COVID: a living systematic review.

Long Covid – The illness narratives.

New guidelines to help doctors manage long COVID patients published.

M-A: More than 50 long-term effects of COVID-19. (vários artigos sobre o tema)

Revisão sistemática | Testes rápidos de carga viral para detectar alta carga viral de HIV em pessoas que vivem com HIV/AIDS em instituições de saúde.

14 Mar, 2022 | 13:48h

Point‐of‐care viral load tests to detect high HIV viral load in people living with HIV/AIDS attending health facilities – Cochrane Library

Resumo: Point-of-care tests for detecting high viral load in people living with HIV attending healthcare facilities – Cochrane Library

Infecções associadas a cuidados de saúde em pacientes adultos de UTI: mudanças em epidemiologia, diagnóstico, prevenção e contribuição das novas tecnologias.

14 Mar, 2022 | 13:44h

Healthcare-associated infections in adult intensive care unit patients: Changes in epidemiology, diagnosis, prevention and contributions of new technologies – Intensive and Critical Care Nursing

Revisão | Infecção cutânea por micobactérias.

14 Mar, 2022 | 13:40h

Mycobacterial skin infection – Current Opinion in Infectious Diseases

Estudo randomizado | Efetividade da fosfomicina no tratamento de infecções de trato urinário por Escherichia coli multirresistente.

14 Mar, 2022 | 13:37h

Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial – JAMA Network Open

Comentários:

The Role of Intravenous Fosfomycin: Finding Our Way Out of Dante’s Forest Dark – JAMA Network Open

Fosfomycin Not Noninferior to Comparators for Bacteremic UTI – HealthDay

‘Forgotten’ antibiotic recovered for resistant bacterial infections – University of Seville

 

Comentário no Twitter

 

Estudo randomizado | Metenamina hipurato (um tratamento preventivo não antibiótico) é não inferior a antibióticos profiláticos para tratar infecções recorrentes de trato urinário em mulheres.

11 Mar, 2022 | 15:19h

Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women: multicentre, open label, randomised, non-inferiority trial – The BMJ

Comunicado de imprensa: Antiseptic drug as good as antibiotics for preventing recurrent urinary tract infections – BMJ Newsroom

Editorial: Methenamine hippurate for recurrent urinary tract infections – The BMJ

Comentários:

Trial supports antibiotic alternative for recurrent urinary infections – CIDRAP

Nonantibiotic Prophylaxis Noninferior for Recurrent UTI – HealthDay

 

Comentário no Twitter

 

Diretriz OMS | Uso de testes diagnósticos rápidos de detecção de antígeno do SARS-CoV-2 para o autoteste de COVID-19.

11 Mar, 2022 | 15:18h

Use of SARS-CoV-2 antigen-detection rapid diagnostic tests for COVID-19 self-testing – World Health Organization

Revisão sistemática | Corticosteroides inalatórios para tratamento da COVID-19.

11 Mar, 2022 | 15:16h

Inhaled corticosteroids for the treatment of COVID‐19 – Cochrane Library

Conteúdos relacionados:

[Preprint] M-A: Inhaled corticosteroids in COVID-19 outpatients.

PRINCIPLE RCT: Inhaled budesonide improves time to recovery from COVID-19 in people at high risk of complications in the community.

Position Paper: Recommendations for the use of topical inhalant budesonide in COVID-19.

RCT: Inhaled budesonide shortens recovery time in non-hospitalized patients with COVID-19

Phase 2 RCT: Inhaled budesonide shows promise for the treatment of early COVID-19

 

Comentário no Twitter (fio – clique para saber mais)

 

Estimativa do excesso de mortalidade decorrente da pandemia de COVID-19.

11 Mar, 2022 | 15:15h

Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21 – The Lancet

Comunicado de imprensa: Global death toll of COVID-19 pandemic may be more than three times higher than official records, estimates of excess deaths indicate – The Lancet

Comentários:

COVID’s true death toll: far higher than official records – Nature

Covid deaths probably three times higher than records say – BBC

Conteúdos relacionados:

Editorial: “Excess deaths” is the best metric for tracking the pandemic.

The pandemic’s true death toll: millions more than official counts.

We can be confident there have been far more than 5 million global Covid deaths – “Estimating ‘excess’ fatalities, a more robust analysis method, puts the pandemic’s grim toll between 10m and 19m people”.

Global Covid-19 deaths surpass five million.

Effects of the Covid-19 pandemic on life expectancy and premature mortality in 2020 – this time series analysis showed there were more than 28 million excess years of life lost in 2020 in 31 countries.

Under-reporting of deaths limits our understanding of true burden of covid-19.

Study shows COVID-19 has caused the biggest decrease in life expectancy since World War II.

Just how do deaths due to COVID-19 stack up?

Tracking excess mortality across countries during the COVID-19 pandemic with the World Mortality Dataset.

Exploring the gap between excess mortality and COVID-19 deaths in 67 countries.

Report: Three new estimates of India’s all-cause excess mortality during the COVID-19 Pandemic – pandemic death toll estimated to be between 3.4 million and 4.9 million excess deaths.

COVID-19 has caused 6.9 million deaths globally, more than double what official reports show

 

Comentário no Twitter

 

Outro estudo sugere que a 3ª dose de vacina é necessária para proteger as populações contra a variante Ômicron.

11 Mar, 2022 | 15:13h

Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study – The BMJ

Comunicado de imprensa: Third vaccine dose critical for protecting populations against omicron variant – BMJ Newsroom

 

Comentário no Twitter

 

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.